Capital Insight Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-40,617
Closed -$895K 167
2024
Q4
$895K Buy
40,617
+26,617
+190% +$587K 0.15% 104
2024
Q3
$252K Buy
+14,000
New +$252K 0.04% 147